Autism and Clostridium tetani

被引:151
作者
Bolte, ER
机构
[1] 705 Misty Creek Drive, New Lenox
关键词
D O I
10.1016/S0306-9877(98)90107-4
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Autism is a severe developmental disability believed to have multiple etiologies. This paper outlines the possibility of a subacute, chronic tetanus infection of the intestinal tract as the underlying cause for symptoms of autism observed in some individuals. A significant percentage of individuals with autism have a history of extensive antibiotic use. Oral antibiotics significantly disrupt protective intestinal microbiota, creating a favorable environment for colonization by opportunistic pathogens. Clostridium tetani is an ubiquitous anaerobic bacillus that produces a potent neurotoxin. Intestinal colonization by C. tetani, and subsequent neurotoxin release, have been demonstrated in laboratory animals which were fed vegetative cells. The vagus nerve is capable of transporting tetanus neurotoxin (TeNT) and provides a route of ascent from the intestinal tract to the CNS. This route bypasses TeNT's normal preferential binding sites in the spinal cord, and therefore the symptoms of a typical tetanus infection are not evident. Once in the brain, TeNT disrupts the release of neurotransmitters by the proteolytic cleavage of synaptobrevin, a synaptic vesicle membrane protein. This inhibition of neurotransmitter release would explain a wide variety of behavioral deficits apparent in autism. Lab animals injected in the brain with TeNT have exhibited many of these behaviors. Some children with autism have also shown a significant reduction in stereotyped behaviors when treated with antimicrobials effective against intestinal clostridia. When viewed as sequelae to a subacute, chronic tetanus infection, many of the puzzling abnormalities of autism have a logical basis. A review of atypical tetanus cases, and strategies to test the validity of this paper's hypothesis, are included.
引用
收藏
页码:133 / 144
页数:12
相关论文
共 117 条
[1]   GLIAL FIBRILLARY ACIDIC PROTEIN IN THE CEREBROSPINAL-FLUID OF CHILDREN WITH AUTISM AND OTHER NEUROPSYCHIATRIC DISORDERS [J].
AHLSEN, G ;
ROSENGREN, L ;
BELFRAGE, M ;
PALM, A ;
HAGLID, K ;
HAMBERGER, A ;
GILLBERG, C .
BIOLOGICAL PSYCHIATRY, 1993, 33 (10) :734-743
[2]   TREATMENT OF TETANUS - AN OPEN STUDY TO COMPARE THE EFFICACY OF PROCAINE PENICILLIN AND METRONIDAZOLE [J].
AHMADSYAH, I ;
SALIM, A .
BRITISH MEDICAL JOURNAL, 1985, 291 (6496) :648-650
[3]   MOLECULAR ASPECTS OF TETANUS AND BOTULINUM NEUROTOXIN POISONING [J].
AHNERTHILGER, G ;
BIGALKE, H .
PROGRESS IN NEUROBIOLOGY, 1995, 46 (01) :83-96
[4]  
American Psychiatric Association, 1994, DIAGN STAT MAN MENT, P65
[5]  
[Anonymous], 1993, J ORTHOMOL MED
[6]   TETANUS TOXIN AS A NEUROBIOLOGICAL TOOL TO STUDY MECHANISMS OF NEURONAL CELL-DEATH IN THE MAMMALIAN BRAIN [J].
BAGETTA, G ;
NISTICO, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 62 (1-2) :29-39
[7]   GLUTAMATE TRANSMISSION IS INVOLVED IN THE MECHANISMS OF NEURONAL DEGENERATION PRODUCED BY INTRAHIPPOCAMPAL TETANUS TOXIN IN RATS [J].
BAGETTA, G ;
NISTICO, G .
TOXICOLOGY LETTERS, 1992, 64-5 :447-453
[8]  
Baker AB, 1942, J NEUROPATHOL EXP NE, V1, P394
[9]  
BAKER SM, 1995, DEF AUT NOW DAN C DA
[10]   URINARY FREE AND CONJUGATED CATECHOLAMINES AND METABOLITES IN AUTISTIC-CHILDREN [J].
BARTHELEMY, C ;
BRUNEAU, N ;
COTTETEYMARD, JM ;
DOMENECHJOUVE, J ;
GARREAU, B ;
LELORD, G ;
MUH, JP ;
PEYRIN, L .
JOURNAL OF AUTISM AND DEVELOPMENTAL DISORDERS, 1988, 18 (04) :583-591